<DOC>
	<DOCNO>NCT01459276</DOCNO>
	<brief_summary>The purpose study determine immunogenicity tolerability one 0.5 mL intramuscular ( IM ) injection FLUVAL AB-like trivalent influenza vaccine contain 6μgHA seasonal A/H1N1 , A/H3N2 B influenza antigens adult elderly people .</brief_summary>
	<brief_title>A Study Evaluate Safety Immunogenicity FluvalAB-like Influenza Vaccine Non-Elderly Adult Elderly Subjects</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>male female adult volunteer age 18 year old , mentally competent , able understand comply study requirement , willing able give write informed consent prior initiation study procedure , good health ( determined clinical judgement investigator basis medical history exist medical condition ) stable medical condition . Subjects exclude know , adequately treat , clinically significant organ systemic disease ( e.g . asthma diabetes ) , , opinion investigator , significance disease compromise subject 's participation study . Female subject age 18 60 year ( i.e . participant childbearing potential ) negative result urine pregnancy test prior vaccination agree use acceptable contraception method abstinence throughout trial become pregnant duration study . Absence existence exclusion criterion . Pregnancy , breastfeed positive urine pregnancy test baseline prior vaccination . Female subject able bear child willing use acceptable contraception method duration study . Hypersensitivity egg , chicken protein , thiomersal , formaldehyde , gentamycin , ciprofloxacin , neomycin component vaccine ; History anaphylactic shock neurological symptom sign follow administration vaccine ; History GuillainBarré syndrome ; Serious disease , cancer , autoimmune disease , advance arteriosclerotic disease , complicate diabetes mellitus , acute progressive hepatic disease , acute progressive renal disease , congestive heart failure ; Immunosuppressive therapy within past 36 month ; Concomitant corticosteroid therapy , include highdose inhaled corticosteroid ; Receipt immunostimulants ; Receipt parenteral immunoglobulin , blood product and/or plasma derivates within past 3 month ; Suspected known HIV , HBV HCV infection ; Acute disease and/or axillary temperature ≥37oC within past 3 day ; Vaccine therapy within past 4 week ; Influenza vaccination ( kind ) within past 6 month ; Experimental drug therapy within past 4 week ; Concomitant participation another clinical study ; Any condition , opinion investigator , may interfere evaluation study ; Past current psychiatric disease subject upon judgement investigator may effect objective decisionmaking subject ; Alcohol drug abuse subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>seasonal</keyword>
	<keyword>prevention</keyword>
	<keyword>influenza</keyword>
	<keyword>infection</keyword>
	<keyword>influenza vaccine</keyword>
	<keyword>vaccine</keyword>
	<keyword>influenza human</keyword>
</DOC>